🇺🇸 FDA
Patent

US 11060110

Adeno-associated virus vectors for treatment of glycogen storage disease

granted A61KA61K48/0008A61K48/005

Quick answer

US patent 11060110 (Adeno-associated virus vectors for treatment of glycogen storage disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K48/0008, A61K48/005, A61K48/0066, A61K48/0075